Clinical Trial Results: A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of octreotide subcutaneous depot in patients with acromegaly has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Octreotide Subcutaneous Depot (octreotide)

Snippet

Sponsor: Camurus AB | Conditions: Acromegaly | Phase 3 | Status: COMPLETED | Results posted: 2026-08-20